Antimineralization treatments for bioprosthetic heart valves. Assessment of efficacy and safety.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 1434707.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Since calcification limits the durability of contemporary bioprosthetic heart valves, antimineralization treatments are being widely investigated. Potential antimineralization treatments must have sustained prevention of mineralization without adverse effects. The preclinical investigation of efficacy and safety of antimineralization treatments comprises four essential steps: (1) subcutaneous implantation in small animals, (2) in vitro biomechanical studies of hemodynamics and durability, (3) morphology of unimplanted valves, and (4) circulatory implants in large animals.
Medical subject headings
- Bioprosthesis
- Calcinosis
- Heart Valve Diseases
- Heart Valve Prosthesis